JAZZ

230.2602.62%
PL

Philip L. Johnson

Executive VP & CFO

Mr. Philip L. Johnson, also known as Phil, serves as Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals plc since March 1, 2024. He serves as President & Director of Sigilon Therapeutics, Inc. since August 11, 2023. He was President and Director of Akouos, Inc. from December 1, 2022. He has been Vice President, Treasurer & Director at Prevail Therapeutics Inc. since January 21, 2021. He served as Senior Vice President of Finance and Treasurer at Eli Lilly and Company since January 1, 2018 until February 2024and also oversaw additional duties merger & acquisition activity. In his last position, he served as Lilly's Group Vice President of Finance, where he led the Company's treasury and investor relations operations. In this role, he was also responsible for financial and negotiation support for Lilly's business development activities and driving Lilly's efforts with the financial community to drive positive social and economic change for underrepresented groups. He previously spent over 10 years as Lilly's Senior Vice President of Investor Relations, where he worked in close collaboration with the CEO and CFO to build deep relationships with the investment community. Mr. Johnson has financial experience. He served as Vice President for Investor Relations at Eli Lilly and Company since 2007 until January 1, 2018. Mr. Johnson is Vice President, Treasurer and Director of Loxo Oncology, Inc. since February 15, 2019. Mr. Johnson has experience in the capital markets. Mr. Johnson has been with Lilly 22 years, serving in a variety of financial roles in the U.S. and overseas. He was vice president of Finance and chief financial officer for Global Manufacturing and Quality at Eli Lilly and Company. Mr. Johnson worked for six years in investment banking and management consulting in the U.S. and Europe. Prior to his tenure at Lilly, he was a consultant at McKinsey & Company and worked in a variety of finance roles at other firms, primarily in mergers and acquisitions. He currently serves on several Boards, including the Indiana Chamber of Commerce and the Indianapolis Urban League. He also serves on the Board of Directors of Equity 1821, Lynx Capital and AMR Action Fund. He holds a Bachelor of Science in Finance from the University of Illinois and a Master of Management from the Kellogg School of Management at Northwestern University.

Positions